Literature DB >> 24411718

Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men.

Jan Philipp Schuchardt1, Simone Schmidt2, Gaby Kressel2, Ina Willenberg3, Bruce D Hammock4, Andreas Hahn2, Nils Helge Schebb3.   

Abstract

INTRODUCTION: Long chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) such as EPA and DHA have been shown to possess beneficial health effects, and it is believed that many of their effects are mediated by their oxygenated products (oxylipins). Recently, we have shown that serum levels of several hydroxy, epoxy, and dihydroxy FAs are dependent on the individual status of the parent FAs in a cohort of normo- and hyperlipidemic subjects. So far, the effect of an increased dietary LC n-3 PUFA intake on hydroxy, epoxy, and dihydroxy FA levels has not been investigated in subjects with mild combined hyperlipidemia. SUBJECTS AND METHODS: In the present study, we compared oxylipin patterns of 10 hyperlipidemic (cholesterol >200mg/dl; triglyceride >150mg/ml) and 10 normolipidemic men in response to twelve weeks of LC n-3 PUFA intake (1.14g DHA and 1.56g EPA). Levels of 44 free hydroxy, epoxy and dihydroxy FAs were analyzed in serum by LC-MS. Additionally, oxylipin levels were compared with their parent PUFA levels in erythrocyte membranes; a biomarker for the individual PUFA status.
RESULTS: Differences in the oxylipin pattern between normo- and hyperlipidemic subjects were minor before and after treatment. In all subjects, levels of EPA-derived oxylipins (170-4800pM) were considerably elevated after LC n-3 PUFA intake (150-1400%), the increase of DHA-derived oxylipins (360-3900pM) was less pronounced (30-130%). The relative change of EPA in erythrocyte membranes is strongly correlated (r≥0.5; p<0.05) with the relative change of corresponding epoxy and dihydroxy FA serum levels. The effect on arachidonic acid (AA)-derived oxylipin levels (140-27,100pM) was inconsistent. DISCUSSION AND
CONCLUSIONS: The dietary LC PUFA composition has a direct influence on the endogenous oxylipin profile, including several highly biological active EPA- and DHA-derived lipid mediators. The shift in oxylipin pattern appears to be dependent on the initial LC PUFA status particularly for EPA. The finding that also levels of other oxylipins derived from ALA, LA or AA are modified by LC n-3 PUFA intake might suggest that at least some of the effects of EPA and DHA could be mediated by a shift in the entire oxylipin profile.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; DHA; Diols; EPA; Eicosanoids; Epoxides; Hyperlipidemia; Omega-3 fatty acids; PUFA

Mesh:

Substances:

Year:  2013        PMID: 24411718      PMCID: PMC4130704          DOI: 10.1016/j.plefa.2013.12.008

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  35 in total

Review 1.  Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate.

Authors:  A R Brash
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

2.  Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.

Authors:  H M Vidgren; J J Agren; U Schwab; T Rissanen; O Hänninen; M I Uusitupa
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

Review 3.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles.

Authors:  Christophe Morisseau; Bruce D Hammock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

4.  Soluble epoxide hydrolase is a therapeutic target for acute inflammation.

Authors:  Kara R Schmelzer; Lukas Kubala; John W Newman; In-Hae Kim; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

Review 5.  Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.

Authors:  Graham C Burdge; Philip C Calder
Journal:  Reprod Nutr Dev       Date:  2005 Sep-Oct

6.  Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

Authors:  Jing Cao; Kerry A Schwichtenberg; Naomi Q Hanson; Michael Y Tsai
Journal:  Clin Chem       Date:  2006-10-19       Impact factor: 8.327

7.  Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes.

Authors:  J Bylund; T Kunz; K Valmsen; E H Oliw
Journal:  J Pharmacol Exp Ther       Date:  1998-01       Impact factor: 4.030

Review 8.  Cytochrome P450 pathways of arachidonic acid metabolism.

Authors:  Deanna L Kroetz; Darryl C Zeldin
Journal:  Curr Opin Lipidol       Date:  2002-06       Impact factor: 4.776

9.  Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men.

Authors:  Jan Philipp Schuchardt; Simone Schmidt; Gaby Kressel; Hua Dong; Ina Willenberg; Bruce D Hammock; Andreas Hahn; Nils Helge Schebb
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-05-19       Impact factor: 4.006

Review 10.  Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements.

Authors:  Mélanie Plourde; Stephen C Cunnane
Journal:  Appl Physiol Nutr Metab       Date:  2007-08       Impact factor: 2.665

View more
  19 in total

1.  Dietary Docosahexaenoic Acid and trans-10, cis-12-Conjugated Linoleic Acid Differentially Alter Oxylipin Profiles in Mouse Periuterine Adipose Tissue.

Authors:  Yuriko Adkins; Benjamin J Belda; Theresa L Pedersen; Dawn M Fedor; Bruce E Mackey; John W Newman; Darshan S Kelley
Journal:  Lipids       Date:  2017-04-13       Impact factor: 1.880

2.  Profiling of Endogenous and Gut Microbial Metabolites to Indicate Metabotype-Specific Dietary Responses: A Systematic Review.

Authors:  Stefania Noerman; Marjukka Kolehmainen; Kati Hanhineva
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

3.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

Review 4.  ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.

Authors:  Weicang Wang; Julia Zhu; Fei Lyu; Dipak Panigrahy; Katherine W Ferrara; Bruce Hammock; Guodong Zhang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-07-11       Impact factor: 3.072

5.  Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins.

Authors:  Nils Helge Schebb; Annika I Ostermann; Jun Yang; Bruce D Hammock; Andreas Hahn; Jan Philipp Schuchardt
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-05-29       Impact factor: 3.072

6.  Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA.

Authors:  Jan Philipp Schuchardt; Inga Schneider; Ina Willenberg; Jun Yang; Bruce D Hammock; Andreas Hahn; Nils Helge Schebb
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-03-22       Impact factor: 3.072

7.  Harmonized procedures lead to comparable quantification of total oxylipins across laboratories.

Authors:  Malwina Mainka; Céline Dalle; Mélanie Pétéra; Jessica Dalloux-Chioccioli; Nadja Kampschulte; Annika I Ostermann; Michael Rothe; Justine Bertrand-Michel; John W Newman; Cécile Gladine; Nils Helge Schebb
Journal:  J Lipid Res       Date:  2020-08-26       Impact factor: 5.922

Review 8.  Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.

Authors:  Hans O Kalkman; Martin Hersberger; Suzanne Walitza; Gregor E Berger
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 9.  Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents.

Authors:  Rui Xue Zhang; Franky Fuh-Ching Liu; Hoyin Lip; Junhong Liu; Qianrong Zhang; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2022-01-22       Impact factor: 5.671

10.  Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation.

Authors:  Sandra Gouveia-Figueira; Jana Späth; Angela M Zivkovic; Malin L Nording
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.